Humana Inc. (HUM) Trading 4% Higher
Humana Inc. (NYSE:HUM)’s share price traded up 4% on Wednesday . The company traded as high as $161.46 and last traded at $160.90, with a volume of 1,961,692 shares. The stock had previously closed at $154.71.
A number of equities analysts recently weighed in on the stock. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a report on Saturday. JPMorgan Chase & Co. downgraded shares of Humana from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $196.00 to $150.00 in a report on Friday, July 8th. Credit Suisse Group AG reaffirmed a “hold” rating on shares of Humana in a report on Tuesday, June 28th. Wolfe Research assumed coverage on shares of Humana in a report on Tuesday, June 28th. They set a “market perform” rating and a $244.00 price objective on the stock. Finally, Leerink Swann reaffirmed an “outperform” rating on shares of Humana in a report on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $206.00.
The firm has a 50-day moving average of $179.43 and a 200-day moving average of $175.09. The company has a market cap of $24.04 billion and a P/E ratio of 22.49.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, May 4th. The insurance provider reported $1.86 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.81 by $0.05. During the same quarter in the prior year, the firm earned $2.58 earnings per share. The firm had revenue of $13.80 billion for the quarter, compared to the consensus estimate of $13.80 billion. The company’s revenue for the quarter was down .2% compared to the same quarter last year. On average, equities analysts anticipate that Humana Inc. will post $8.87 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be paid a dividend of $0.29 per share. The ex-dividend date is Tuesday, June 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.72%.
Other large investors have recently added to or reduced their stakes in the company. ProShare Advisors LLC increased its stake in Humana by 6.0% in the fourth quarter. ProShare Advisors LLC now owns 27,297 shares of the insurance provider’s stock worth $4,873,000 after buying an additional 1,556 shares in the last quarter. Napier Park Global Capital US LP purchased a new stake in Humana during the fourth quarter worth about $5,355,000. Gabelli Funds LLC increased its stake in Humana by 21.9% in the fourth quarter. Gabelli Funds LLC now owns 65,450 shares of the insurance provider’s stock worth $11,683,000 after buying an additional 11,750 shares in the last quarter. Commerzbank Aktiengesellschaft FI increased its stake in Humana by 52.0% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 8,869 shares of the insurance provider’s stock worth $1,583,000 after buying an additional 3,035 shares in the last quarter. Finally, OppenheimerFunds Inc. increased its stake in Humana by 31.2% in the fourth quarter. OppenheimerFunds Inc. now owns 113,512 shares of the insurance provider’s stock worth $20,271,000 after buying an additional 27,005 shares in the last quarter.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.